Dataset opportunity
Epflex — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Epflex, usable for Regulatory RAG and Compliance Copilots.
Score
69.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
License
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in healthcare regulatory affairs market = $1.2B in 2024, CAGR 16.7%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
Focus on data-driven analysis in R&D engineering roles
source ↗
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
Medium
Accessibility
Partial
Legal
Owned by the company — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Epflex holds a comprehensive Regulatory Records Dataset in Text modality, containing technical and clinical documentation, regulatory filings, and knowledge bases essential for medical device compliance. This structured and unstructured data, covering decades of regulatory history, is exceptionally suited for developing a high-precision Regulatory RAG model to navigate complex international standards and submission processes.
The global AI in healthcare regulatory affairs market is a rapidly expanding field, valued at $1.2B in 2024 with a projected CAGR of 16.7%. Despite access complexities due to MDR/ISO 13485 constraints, highly sensitive trade secrets on proprietary processes, and a family-owned structure requiring direct engagement, the dataset's rarity and direct applicability offer a significant competitive advantage, justifying the strategic effort to unlock its value. ⚠ Diligence (valuable data, access to negotiate): Medical regulatory constraints (MDR/ISO 13485) apply to technical and clinical documentation.; Proprietary manufacturing processes for Nitinol and ePTFE are highly sensitive trade secrets.; Family-owned German SME structure may require high-trust, direct engagement with the Uihlein family management. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Epflex owns a proprietary dataset of regulatory documentation and intellectual property for complex medical devices. This data is a prime asset for RegTech and compliance-AI vendors seeking to build and train sophisticated Regulatory RAG models. In a healthcare regulatory AI market growing at over 16% annually, this dataset offers a distinct advantage by providing authentic, real-world compliance and patent text that is not publicly available.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
proprietary domain data (open lowers rarity)
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/open (current)
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
High buyer demand is driven by the urgent need for AI-powered solutions to manage increasing regulatory complexity in the healthcare sector, a market growing at a 16.7% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility56
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Epflex is an ideal target: a family-owned German SME that is a leading OEM manufacturer of medical guidewires and components, generating valuable production and regulatory data as a byproduct of its core operational business.
- Deep Qualification80
✓ pass — Epflex is a strong candidate. As an OEM manufacturer of medical devices, it inherently produces the specified 'Regulatory Records Dataset' as a byproduct of its core business. The data is company-owned, and the business model aligns perfectly with the opportunity.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
The company provides a dedicated portal for document downloads, indicating a structured process for distributing technical specifications and other proprietary files valuable for B2B data acquisition.
Industrial data
This text confirms the company generates data from physical product testing and material science analysis, providing empirical, data-driven evidence that underpins and validates its regulatory filings.
Regulatory records
Epflex explicitly creates and manages documentation compliant with key international medical device regulations, including ISO 13485 and the European MDR, making this a high-value source for real-world compliance data.
Knowledge base / docs
The holder possesses a significant portfolio of intellectual property, with patents for specific medical devices, offering a unique and proprietary corpus of highly technical and legal text for model training.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Epflex Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in healthcare regulatory affairs market = $1.2B in 2024, CAGR 16.7% (source: Transparency Market Research).. Investment score 69.9/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Robsurgical — Medical Imaging Dataset Opportunity
View opportunity →mobilityZolldex — Regulatory Records Dataset Opportunity
View opportunity →otherAlliancedesenergies — Regulatory Records Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- Data marketplaces, explained4 min read
- Data licensing, term by term4 min read
- Is Your Data Worth Money?3 min read